Cover Story
Endo_News0413F1-page-001

Metabolic Breakthrough

Hormone fibroblast growth factor 21 holds promise for treating diabetes, obesity, and metabolic syndrome, but new drug treatments remain years away

Read More

Features

  • HOPE for Adrenal Cancer

    Despite some disappointing studies, researchers pursue IGF2 and other suspects for drug targets

    Read More

  • Hypertension ESAP Case

    HYPERTENSION MYSTERY: A Case Study From ESAP™ A45-year-old woman presents with a nine-year history of hypertension. Her current antihypertensive medications include amlodipine, 10 mg dai...

    Read More

  • Flexing MUSSELS

    Glue secreted by these bivalves could prove effective in treatments for numerous cardiovascular diseases

    Read More

  • The 38,460 MENACE

    Deadly pancreatic cancer demands resourceful treatment approach

    Read More